OptimizeRx (OPRX) Payables (2010 - 2026)

OptimizeRx has disclosed Payables across 17 years of filings, most recently posting $1.3 million for Q2 2026.

• In Q2 2026, Payables fell 33.25% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $1.3 million (down 33.25% YoY), while the FY2025 annual figure was $1.6 million, down 24.12% from the prior year.
• Payables came in at $1.3 million for Q2 2026 at OptimizeRx, down from $3.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $3.4 million in Q1 2025 to a low of $600729.0 in Q1 2022.
• Average Payables over 5 years is $1.8 million, with a median of $1.7 million recorded in 2024.
• Year-over-year, Payables tumbled 36.9% in 2023 and soared 298.46% in 2024.
• Over 5 years, Payables stood at $1.5 million in 2022, then jumped by 43.68% to $2.2 million in 2023, then fell by 3.19% to $2.2 million in 2024, then fell by 24.12% to $1.6 million in 2025, then declined by 19.13% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.3 million in Q2 2026, $3.1 million in Q1 2026, and $1.6 million in Q4 2025.